Thus, the MMTV-HER2/Neu mouse model appeared to be ideal for further assessment of the effects of NRTI on spontaneous breast tumor development, tumor response to chemotherapy using DMAG-17, and progression-free survival (time of refractory tumor relapses). This evidence concerns the gene ERBB2 and neoplasm.